Dr Reddy's confirms co waiting for nod for semaglutide injection in Canada
This story was originally published at 10:29 IST on 24 April 2026
Register to read our real-time news.Informist, Friday, Apr. 24, 2026
MUMBAI – Dr. Reddy's Laboratories Ltd. Friday confirmed it is still awaiting approval for its semaglutide injection from Canada's healthcare regulator, Health Canada. The company got drug identification numbers for the injection from Health Canada on Apr. 22, it said in a notice to stock exchanges. Dr. Reddy's is in talks with the health authority to introduce the injection in the country, it said.
Dr. Reddy's issued the clarification after CNBC-TV18 Thursday reported citing sources that the company is awaiting approval for semaglutide in Canada. Shares of the pharmaceutical company had surged over 9% Thursday after the media outlet's report.
For the quarter ended December, the company's consolidated net profit was INR 12.1 billion and its revenue was INR 87.53 billion. At 1025 IST, shares of the company were down nearly 2% at INR 1,306.20 on National Stock Exchange. End
IST, or Indian Standard Time, is five-and-a-half hours ahead of GMT
Reported by Ruchira Kagita
Edited by Ashish Shirke
For users of real-time market data terminals, Informist news is available exclusively on the NSE Cogencis WorkStation.
Cogencis news is now Informist news. This follows the acquisition of Cogencis Information Services Ltd. by NSE Data & Analytics Ltd., a 100% subsidiary of the National Stock Exchange of India Ltd. As a part of the transaction, the news department of Cogencis has been sold to Informist Media Pvt. Ltd.
Informist Media Tel +91 (22) 6985-4000
Send comments to feedback@informistmedia.com
© Informist Media Pvt. Ltd. 2026. All rights reserved.
To read more please subscribe
Share this Story:
